These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31106679)

  • 1. The component changes of lysophospholipid mediators in colorectal cancer.
    Kitamura C; Sonoda H; Nozawa H; Kano K; Emoto S; Murono K; Kaneko M; Hiyoshi M; Sasaki K; Nishikawa T; Shuno Y; Tanaka T; Hata K; Kawai K; Aoki J; Ishihara S
    Tumour Biol; 2019 May; 41(5):1010428319848616. PubMed ID: 31106679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Lysophospholipid Components in Ulcerative Colitis and Colitis-associated Cancer.
    Sonoda H; Kitamura C; Kano K; Anzai H; Nagai Y; Abe S; Yokoyama Y; Ishii H; Kishikawa J; Murono K; Emoto S; Sasaki K; Kawai K; Nozawa H; Aoki J; Ishihara S
    Anticancer Res; 2022 May; 42(5):2461-2468. PubMed ID: 35489747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Lysophosphatidylinositol Signaling-relevant Molecules in Colorectal Cancer.
    Kitamura C; Sonoda H; Anzai H; Nagai Y; Abe S; Yokoyama Y; Ishii H; Kishikawa J; Emoto S; Murono K; Sasaki K; Kawai K; Nozawa H; Ishihara S
    Anticancer Res; 2021 May; 41(5):2349-2355. PubMed ID: 33952459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
    Murph M; Tanaka T; Pang J; Felix E; Liu S; Trost R; Godwin AK; Newman R; Mills G
    Methods Enzymol; 2007; 433():1-25. PubMed ID: 17954226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyper-Elongation in Colorectal Cancer Tissue - Cerotic Acid is a Potential Novel Serum Metabolic Marker of Colorectal Malignancies.
    Mika A; Kobiela J; Czumaj A; Chmielewski M; Stepnowski P; Sledzinski T
    Cell Physiol Biochem; 2017; 41(2):722-730. PubMed ID: 28214830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids.
    Kurano M; Dohi T; Nojiri T; Kobayashi T; Hirowatari Y; Inoue A; Kano K; Matsumoto H; Igarashi K; Nishikawa M; Miyauchi K; Daida H; Ikeda H; Aoki J; Yatomi Y
    BBA Clin; 2015 Dec; 4():92-8. PubMed ID: 26675681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol.
    Makide K; Kitamura H; Sato Y; Okutani M; Aoki J
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):135-9. PubMed ID: 19427394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of lysophospholipid levels in rat feces with those in a standard chow.
    Inoue M; Adachi M; Shimizu Y; Tsutsumi T; Tokumura A
    J Agric Food Chem; 2011 Jul; 59(13):7062-7. PubMed ID: 21648420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer.
    De la Fuente López M; Landskron G; Parada D; Dubois-Camacho K; Simian D; Martinez M; Romero D; Roa JC; Chahuán I; Gutiérrez R; Lopez-K F; Alvarez K; Kronberg U; López S; Sanguinetti A; Moreno N; Abedrapo M; González MJ; Quera R; Hermoso-R MA
    Tumour Biol; 2018 Nov; 40(11):1010428318810059. PubMed ID: 30419802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding modulations of lipid mediators in cancer using a murine model of carcinomatous peritonitis.
    Kurano M; Sakai E; Yatomi Y
    Cancer Med; 2022 Sep; 11(18):3491-3507. PubMed ID: 35315587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids.
    Xiao Y; Guengerich FP
    J Lipid Res; 2012 Aug; 53(8):1610-7. PubMed ID: 22591743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic acid production and action: validated targets in cancer?
    Umezu-Goto M; Tanyi J; Lahad J; Liu S; Yu S; Lapushin R; Hasegawa Y; Lu Y; Trost R; Bevers T; Jonasch E; Aldape K; Liu J; James RD; Ferguson CG; Xu Y; Prestwich GD; Mills GB
    J Cell Biochem; 2004 Aug; 92(6):1115-40. PubMed ID: 15258897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.
    Ning W; Li H; Meng F; Cheng J; Song X; Zhang G; Wang W; Wu S; Fang J; Ma K; Yang J; Pei D; Dong F
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses.
    Xiao Y; Chen Y; Kennedy AW; Belinson J; Xu Y
    Ann N Y Acad Sci; 2000 Apr; 905():242-59. PubMed ID: 10818458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel lysophosphoplipid receptors: their structure and function.
    Makide K; Uwamizu A; Shinjo Y; Ishiguro J; Okutani M; Inoue A; Aoki J
    J Lipid Res; 2014 Oct; 55(10):1986-95. PubMed ID: 24891334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
    Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
    World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between the expression of DDX39 protein and prognosis of colorectal cancer].
    Ma J; Chang W; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):336-341. PubMed ID: 29577224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
    Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
    Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
    Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
    World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.